Hil Moss: Excited to share the next chapter in our mission to radically redefine cancer survivorship care
Hil Mos, Co-Founder and CEO of OncoveryCare, shared on LinkedIn: .
“Today, I’m excited to share the next chapter in our mission to radically redefine cancer survivorship care.
When I was in my final year of grad school and decided to make the jump to start our cancer survivorship company—which, today, reintroduces itself as OncoveryCare—I would fantasize about what it would be like to work arm-in-arm with a team on this mission.
That’s why the highlight of the past two years, by far, has been meeting my amazing Co-Founder, Dr. Justin Grischkan; our Founding Team members Natasha Steele and Alicia Tan; and every single one of our incredible team members, advisors, and early investors.
This morning, we officially introduce some incredible additions to Team Oncovery, as we announce both our anchor partnership with Tennessee Oncology (led by the incredible Dr. Natalie Dickson), as well as our $4.5 million Seed financing led by .406 Ventures alongside Tennessee Oncology’s McKay Institute for Innovation. Existing investors Oncology Ventures and Techstars continue supporting our vision as well.
So much to share on this in the days and weeks ahead, but you can read more here, and we figured we’d re-introduce ourselves (with new faces!) in the video below.
As always, grateful to be on this journey together.”
Proceed to the video.
Source: Hil Moss/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023